Matthew Barbour, PHARMD
Pharmacist · Fremont, OH
Matthew Barbour, PHARMD is a pharmacist with a practice address in Fremont, Ohio, and NPI 1285167627, issued on Apr 4, 2017. Check the license (Ohio 03334936, as entered in NPPES) with the Ohio board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Matthew Barbour
- Credential
- PHARMD
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 03334936 OH
Self-reported in NPPES; status is on the state search - Practice location
- 715 S Taft Ave, Fremont, OH 43420
- Phone
- (419) 334-6618
- Enumerated
- Apr 4, 2017
- Entity
- Type 1 · individual
Also registered at 715 S Taft Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Suzanne Amidon Magro, D.O.Emergency Medicine Physician1407941198
- Iracema Arevalo, M.DPediatric Infectious Diseases Physician1962620294
- Laraine Bauer, PTPhysical Therapist1356440044
- Patricia Beaschler, RPHPharmacist1750814992
- Bonnie Bowlus, PTPhysical Therapist1801985668
- Ernest Buck, M.D.Emergency Medicine Physician1861504987
Verify Matthew Barbour in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Ohio board licenses this profession
Search for license 03334936Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
85% fewer Medicare Part D claims than the average pharmacist in 2024
19 Medicare Part D claims, against an average of 127 among the 28,933 providers of this specialty who prescribed in Part D.
Most prescribed
- Warfarin Sodium15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
25 pharmacist records list a Fremont practice address
They are 25 of the 525 NPPES records with a Fremont practice address, and 10,879 pharmacist records in Ohio.
All 25 in Fremont → All 10,879 in Ohio → Every provider in Fremont →
Other pharmacist records in Ohio
- Bridget Aalseth, PHARMDWorthington, OH1184227050
- Sherry Abadir, RPHSeven Hills, OH1043911373
- Desta Abay, PHARMDWhitehall, OH1740884949
- Courtney Abbott, PHARMDFremont, OH1326262940
- Dennis Abbott, RPHOregon, OH1972884310
- Abbas AbdallaColumbus, OH1003473935
- Samah AbdallahBoardman, OH1689410433
- Sulafa AbdallahSylvania, OH1053272336
- Kristina Abdelaal, RPHPowell, OH1598448763
- Rasha AbdelbakyCleveland, OH1689117731
Common questions
What is Matthew Barbour, PHARMD's NPI number?
Matthew Barbour, PHARMD's National Provider Identifier (NPI) is 1285167627, issued on Apr 4, 2017. An NPI identifies a provider in billing; it is not a license.
Where is Matthew Barbour, PHARMD located?
The NPPES record lists a practice address at 715 S Taft Ave, Fremont, OH, 43420. Phone: (419) 334-6618. Providers update this record themselves, so call before visiting.
How can I verify Matthew Barbour, PHARMD's license?
NPPES lists Ohio license number 03334936, as entered by the provider. Search the Ohio board that licenses this profession; the NPPES record confirms identity only.
How much does Matthew Barbour, PHARMD prescribe under Medicare Part D?
In 2024, Matthew Barbour, PHARMD had 19 Medicare Part D claims; the average among pharmacist prescribers was 127. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.